Related Experiment Video
Updated: Apr 21, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
TRIFUNCTIONAL LIGANDS: A RADIOIODINATED HIGH AFFINITY ACYLATING ANTAGONIST FOR THE A1 ADENOSINE RECEPTOR
Kenneth A Jacobson1, Mark E Olah1, Gary L Stiles1
1Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
Researchers developed a novel radioligand, BH-DITC-XAC, for adenosine A1 receptors. This tool covalently binds to receptors, enabling precise labeling and characterization of A1 receptor proteins in brain tissue.
Area of Science:
- Pharmacology
- Neuroscience
- Radiochemistry
Background:
- Adenosine receptors, particularly the A1 subtype, play crucial roles in neurological functions.
- Developing specific probes for these receptors is essential for understanding their function and for drug discovery.
Purpose of the Study:
- To synthesize and characterize a novel xanthine-based radioligand capable of covalent binding to adenosine A1 receptors.
- To utilize this radioligand as a probe for identifying and studying A1 receptor proteins.
Main Methods:
- Synthesis of BH-DITC-XAC, a trifunctional aryl diisothiocyanate crosslinker with a radioiodination site.
- Preparation of 125I-BH-DITC-XAC using the chloramine T method and purification by HPLC.
- Binding assays using bovine brain membranes and affinity-purified A1 receptors.
Main Results:
- The synthesized xanthine derivative (BH-DITC-XAC) demonstrated competitive inhibition against known A1 receptor ligands with an IC50 of 40nM.
- Radioiodinated 125I-BH-DITC-XAC specifically bound to A1 receptors, with binding inhibited by adenosine agonists in a dose-dependent manner.
- Incubation with purified A1 receptors resulted in specific labeling of a 36,000 MW polypeptide band, consistent with the known A1 receptor.
Conclusions:
- A novel, covalently binding radioligand (125I-BH-DITC-XAC) was successfully developed for adenosine A1 receptors.
- This radioligand serves as an effective probe for the specific identification and characterization of A1 receptor proteins.
- The findings validate the utility of BH-DITC-XAC in neuropharmacological research and receptor studies.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...

